The minimally invasive spine surgery market is expected to reach $4.16 billion globally, according to a market research report from DataM intelligence.
Five notes:
1. The global MISS market reached $2.67 billion in 2022 and is expected to grow to $4.16 billion, or 5.8% CAGR, by 2031.
2. Market growth is driven by increased prevalence for spinal disorders, aging populations and demand for faster surgical recovery.
3. North America leads the global market share with 35%.
4. The U.S. MISS market is expected to reach $1.2 billion by 2031.
5. Key companies in the MISS market include Zimmer Biomet, DePuy Synthes, Stryker and Medtronic.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.